JENNIFER CARDENAS: Open Payments
NPI 1477067338 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,620 in 59 payments from 23 companies in 2025. Trend: 2023 $331 · 2024 $767 · 2025 $1,620
Food & beverage: $1,328Education: $292
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $170 |
| Incyte Corporation | 4 | $166 |
| Daiichi Sankyo Inc. | 9 | $160 |
| Novartis Pharmaceuticals Corporation | 6 | $160 |
| Janssen Biotech, Inc. | 3 | $144 |
| Astellas Pharma US Inc | 8 | $143 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Eisai Inc. | 3 | $76 |
| Celgene Corporation | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 4 | $72 |
Products named: Enhertu, SCEMBLIX, LIBTAYO, BOTOX, DARZALEX, Lenvima, REBLOZYL, OPDIVO.
Industry payments across NY — which companies pay providers there.
